News
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
7 Mar 24
Cannabis, Earnings, News
Evogene Q4 EPS $(0.13) Beats $(0.14) Estimate, Sales $578.00K Beat $500.00K Estimate
7 Mar 24
Earnings, News
Earnings Scheduled For March 7, 2024
7 Mar 24
Earnings
Evogene Earnings Preview
6 Mar 24
Earnings
Casterra Announced New Agreements With Seed Producers in Brazil And Africa To Meet Growing Demand ForIts Elite Castor Seed Varieties
5 Mar 24
News, Contracts
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation, Financial Terms Undisclosed
6 Feb 24
News
Press releases
Evogene Announces Filing of Annual Report on Form 20-F
28 Mar 24
Small Cap, Press Releases
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
20 Mar 24
Press Releases
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America
13 Mar 24
Press Releases
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
7 Mar 24
Earnings, Press Releases
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
6 Mar 24
Press Releases
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties
5 Mar 24
Press Releases
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
28 Feb 24
Press Releases
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
26 Feb 24
Press Releases
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
21 Feb 24
Press Releases
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
6 Feb 24
News, Contracts, Small Cap, Press Releases
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
23 Jan 24
Press Releases
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
17 Jan 24
Press Releases